Renascience Inc. (TYO:4889)
Japan · Delayed Price · Currency is JPY 1,121.00
-61.00 (-5.16%)
May 12, 2026, 3:30 PM JST
Renascience Market Cap
Renascience has a market cap or net worth of 15.44 billion as of May 12, 2026. Its market cap has increased by 13.02% in one year.
Market Cap
15.44B
Enterprise Value
13.03B
Revenue
107.00M
Ranking
n/a
PE Ratio
n/a
Stock Price
1,121.00
Market Cap Chart
Since September 24, 2021, Renascience's market cap has increased from 10.13B to 15.44B, an increase of 52.39%. That is a compound annual growth rate of 9.52%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| May 12, 2026 | 15.44B | -16.02% |
| Dec 30, 2025 | 18.39B | 387.08% |
| Dec 30, 2024 | 3.78B | -31.57% |
| Dec 29, 2023 | 5.52B | 18.26% |
| Dec 30, 2022 | 4.67B | -46.27% |
| Dec 30, 2021 | 8.68B | -14.33% |
| Sep 24, 2021 | 10.13B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| AnGes | 20.61B |
| RaQualia Pharma | 19.86B |
| StemRIM | 18.99B |
| Stella Pharma | 16.43B |
| ReproCELL | 15.87B |
| CanBas | 13.23B |
| Immuno-Biological Laboratories | 12.53B |
| Kidswell Bio | 11.46B |